Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Liver stem cells and hepatocellular carcinoma.

Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP.

Hepatology. 2009 Jan;49(1):318-29. doi: 10.1002/hep.22704. Review.

2.

Cancer stem cells and hepatocellular carcinoma.

Yao Z, Mishra L.

Cancer Biol Ther. 2009 Sep;8(18):1691-8. Review.

3.

Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.

Marquardt JU, Factor VM, Thorgeirsson SS.

J Hepatol. 2010 Sep;53(3):568-77. doi: 10.1016/j.jhep.2010.05.003. Epub 2010 May 31. Review.

4.

Novel therapeutic strategies for targeting liver cancer stem cells.

Oishi N, Wang XW.

Int J Biol Sci. 2011 Apr 26;7(5):517-35. Review.

5.

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra L.

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):530-8. doi: 10.1038/nrgastro.2012.114. Epub 2012 Jun 19. Review.

6.

Hierarchical potential differentiation of liver cancer stem cells.

Zhang W, Mu D, Feng K.

Adv Clin Exp Med. 2017 Oct;26(7):1137-1141. doi: 10.17219/acem/66343. Review.

7.

Developmental signaling pathways in brain tumor-derived stem-like cells.

Clark PA, Treisman DM, Ebben J, Kuo JS.

Dev Dyn. 2007 Dec;236(12):3297-308. Review.

8.

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.

Coulouarn C, Cavard C, Rubbia-Brandt L, Audebourg A, Dumont F, Jacques S, Just PA, Clément B, Gilgenkrantz H, Perret C, Terris B.

Carcinogenesis. 2012 Sep;33(9):1791-6. doi: 10.1093/carcin/bgs208. Epub 2012 Jun 13.

PMID:
22696594
9.

[Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].

Shimizu T, Nakagawa K.

Nihon Rinsho. 2015 Aug;73(8):1342-8. Review. Japanese.

PMID:
26281688
10.

Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.

Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B.

Oncotarget. 2016 Feb 2;7(5):5754-68. doi: 10.18632/oncotarget.6805.

11.

Generating pancreatic beta-cells from embryonic stem cells by manipulating signaling pathways.

Champeris Tsaniras S, Jones PM.

J Endocrinol. 2010 Jul;206(1):13-26. doi: 10.1677/JOE-10-0073. Epub 2010 Apr 12.

12.

Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.

Pang RW, Poon RT.

Curr Cancer Drug Targets. 2012 Nov 1;12(9):1081-94. Review.

PMID:
22873219
13.

A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.

Zhang J, Lai W, Li Q, Yu Y, Jin J, Guo W, Zhou X, Liu X, Wang Y.

Biochem Biophys Res Commun. 2017 Sep 16;491(2):469-477. doi: 10.1016/j.bbrc.2017.07.041. Epub 2017 Jul 8.

PMID:
28698142
14.

Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?

Ceballos MP, Parody JP, Alvarez Mde L, Ingaramo PI, Carnovale CE, Carrillo MC.

Biochem Pharmacol. 2011 Dec 1;82(11):1682-91. doi: 10.1016/j.bcp.2011.08.001. Epub 2011 Aug 6.

PMID:
21843516
15.

Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells.

Yamashita T, Kaneko S.

J Gastroenterol. 2014 Jul;49(7):1105-10. doi: 10.1007/s00535-014-0951-1. Epub 2014 Mar 20. Review.

PMID:
24647548
16.

The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.

Jiang F, Mu J, Wang X, Ye X, Si L, Ning S, Li Z, Li Y.

PLoS One. 2014 May 7;9(5):e96698. doi: 10.1371/journal.pone.0096698. eCollection 2014.

17.

Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.

Shen YN, He HG, Shi Y, Cao J, Yuan JY, Wang ZC, Shi CF, Zhu N, Wei YP, Liu F, Huang JL, Yang GS, Lu JH.

Mol Carcinog. 2017 Feb;56(2):751-760. doi: 10.1002/mc.22532. Epub 2016 Aug 11.

PMID:
27478926
18.

Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).

Song K, Wu J, Jiang C.

Oncol Rep. 2013 Jan;29(1):3-12. doi: 10.3892/or.2012.2082. Epub 2012 Oct 17. Review.

PMID:
23076400
19.

Biology and clinical implications of CD133(+) liver cancer stem cells.

Ma S.

Exp Cell Res. 2013 Jan 15;319(2):126-32. doi: 10.1016/j.yexcr.2012.09.007. Epub 2012 Sep 19. Review.

PMID:
22999864
20.

Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche.

Schotanus BA, Kruitwagen HS, van den Ingh TS, van Wolferen ME, Rothuizen J, Penning LC, Spee B.

BMC Vet Res. 2014 Dec 31;10:309. doi: 10.1186/s12917-014-0309-1.

Supplemental Content

Support Center